Skip to main content
logo
Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
159.85
+3.74 (2.40%)
At close: Jul 28, 2026, 4:00 PM EDT
160.26
+0.41 (0.26%)
After-hours: Jul 28, 2026, 7:34 PM EDT

Novartis AG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
14,95113,52413,86014,35814,83613,62013,55813,17212,87212,12011,77612,09211,74511,04710,96610,78313,08512,81413,52213,367
Revenue Growth (YoY)
0.78%-0.70%2.23%9.00%15.26%12.38%15.13%8.93%9.60%9.71%7.39%12.14%-10.24%-13.79%-18.90%-19.33%-1.57%0.95%3.78%6.61%
Cost of Revenue
3,7103,4593,6113,5393,3223,2273,3243,2343,1733,0963,0223,1173,3422,9913,0412,8743,7513,8563,9763,938
Gross Profit
11,24110,06510,24910,81911,51410,39310,2349,9389,6999,0248,7548,9758,4038,0567,9257,9099,3348,9589,5469,429
Selling, General & Admin
3,2413,1403,4403,3083,4423,0583,5013,1343,0912,8403,4443,0913,0912,8913,1832,9363,5813,5123,9853,618
Research & Development
2,8472,7403,1632,9442,7272,3662,8422,3922,3672,4212,5673,9252,3042,5752,2162,5422,4982,3202,4092,380
Other Operating Expenses
403-503066481306361785227390161197201-287716051,027274590198
Total Operating Expenses
6,4915,8306,6336,3186,6505,7306,7046,3115,6855,6516,1727,2135,5965,4386,1706,0837,1066,1066,9846,196
Operating Income
4,7504,2353,6164,5014,8644,6633,5303,6274,0143,3732,5821,7622,8072,6181,7551,8262,2282,8522,5623,233
Interest Income
-2-3-2-4-3-3-3-4-2-29-6-3-2-2-3-5--214,621223
Interest Expense
-462-343-304-281-289-270-275-264-246-221-217-222-216-200-207-206-202-201-206-202
Other Non-Operating Income (Expense)
-17-50-92-20-4117332675618158510424-281620-26-24
Total Non-Operating Income (Expense)
-481-396-398-305-333-256-245-242-173-244-205-210-133-98-186-239-186-18314,389-3
Pretax Income
4,2693,8393,2184,1964,5314,4073,2853,3853,8413,1292,3771,5522,6742,5201,5691,5872,0422,66916,9513,230
Provision for Income Taxes
1,012683814266507798465200595441-26139403370254257347450645472
Net Income
3,2573,1562,4043,9304,0243,6092,8203,1853,2462,6882,6381,5132,2712,1501,3151,3301,6952,21916,3062,758
Minority Interest in Earnings
-70-52-1732-4000211021-3-20
Earnings From Discontinued Operations
----------5,84225046144151245----
Net Income to Common
3,2643,1562,4093,9284,0413,6062,8183,1893,2462,6888,4801,7612,3162,2931,4661,5731,6942,22216,3082,758
Net Income Growth (YoY)
-19.23%-12.48%-14.51%23.17%24.49%34.15%-66.77%81.09%40.16%17.23%478.44%11.95%36.72%3.19%-91.01%-42.97%-41.51%7.92%678.80%42.53%
Shares Outstanding (Basic)
1,9051,9091,9131,9261,9481,9681,9872,0122,0332,0442,0502,0622,0832,1102,1352,1672,1982,2252,2372,237
Shares Outstanding (Diluted)
1,9141,9161,9291,9401,9601,9792,0042,0272,0462,0562,0652,0752,0952,1202,1502,1802,2112,2372,2532,254
Shares Change (YoY)
-2.35%-3.18%-3.74%-4.29%-4.20%-3.74%-2.95%-2.31%-2.34%-3.02%-3.95%-4.82%-5.25%-5.23%-4.57%-3.28%-2.08%-1.24%-1.27%-2.08%
EPS (Basic)
1.711.651.262.042.071.831.421.581.601.314.140.851.111.090.690.730.771.007.291.23
EPS (Diluted)
1.711.651.252.022.061.821.411.571.591.314.110.851.111.080.680.720.770.997.241.22
EPS Growth (YoY)
-16.99%-9.34%-11.35%28.66%29.56%38.93%-65.69%84.71%43.24%21.30%504.41%18.06%44.16%9.09%-90.61%-40.98%-39.84%8.79%686.96%45.24%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
5,5613,3301,6556,2176,3333,3913,6355,9654,6152,0382,1415,1173,3512,7203,8054,5003,4981,3923,4244,574
Free Cash Flow Growth (YoY)
-12.19%-1.80%-54.47%4.23%37.23%66.39%69.78%16.57%37.72%-25.07%-43.73%13.71%-4.20%95.40%11.13%-1.62%-8.21%-26.11%-1.72%58.98%
Free Cash Flow Per Share
2.911.740.863.203.231.711.812.942.260.991.042.471.601.281.772.061.580.621.522.03
Dividends Per Share
--4.666---3.862---3.919---3.461---3.401-
Dividend Growth (YoY)
--20.81%----1.44%---13.24%---1.77%-----
Gross Margin
75.19%74.42%73.95%75.35%77.61%76.31%75.48%75.45%75.35%74.46%74.34%74.22%71.55%72.92%72.27%73.35%71.33%69.91%70.60%70.54%
Operating Margin
31.77%31.31%26.09%31.35%32.79%34.24%26.04%27.54%31.18%27.83%21.93%14.57%23.90%23.70%16.00%16.93%17.03%22.26%18.95%24.19%
Profit Margin
21.78%23.34%17.34%27.37%27.12%26.50%20.80%24.18%25.22%22.18%22.40%12.51%19.34%19.46%11.99%12.33%12.95%17.32%120.59%20.63%
FCF Margin
37.19%24.62%11.94%43.30%42.69%24.90%26.81%45.29%35.85%16.82%18.18%42.32%28.53%24.62%34.70%41.73%26.73%10.86%25.32%34.22%
EBITDA
6,1565,4435,1525,7936,1165,8585,1905,5995,1543,3734,2071,7624,5444,6611,7553,8312,2284,3594,0934,678
EBITDA Margin
41.17%40.25%37.17%40.35%41.22%43.01%38.28%42.51%40.04%27.83%35.73%14.57%38.69%42.19%16.00%35.53%17.03%34.02%30.27%35.00%
EBIT
4,7504,2353,6164,5014,8644,6633,5303,6274,0143,3732,5821,7622,8072,6181,7551,8262,2282,8522,5623,233
EBIT Margin
31.77%31.31%26.09%31.35%32.79%34.24%26.04%27.54%31.18%27.83%21.93%14.57%23.90%23.70%16.00%16.93%17.03%22.26%18.95%24.19%
Effective Tax Rate
23.71%17.79%25.30%6.34%11.19%18.11%14.16%5.91%15.49%14.09%-10.98%2.51%15.07%14.68%16.19%16.19%16.99%16.86%3.81%14.61%
SEC Filings: 10-K · 10-Q